Single Fraction HDR Brachytherapy for Prostate Cancer: SiFEPI Phase II Trial Results

被引：0
|
作者：
Pujol, N. [1 ]
Pace-Loscos, T. [1 ]
Schiappa, R. [2 ]
Gautier, M. [1 ]
Chand, M. E. [1 ]
Levi, J. M. Hannoun [3 ]
机构：
[1] Antoine Lacassagne Canc Ctr, Nice, France
[2] Univ Cote Azur, Antoine Lacassagne Canc Ctr, Nice, France
[3] Univ Cote Azur, Ctr Antoine Lacassagne, Dept Radiotherapy, Nice, France
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2540
引用
收藏
页码：E242 / E242
页数：1
相关论文
共 50 条
  • [1] Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial
    Hannoun-Levi, Jean -Michel
    Chand-Fouche, Marie-Eve
    Pace-Loscos, Tanguy
    Gautier, Mathieu
    Gal, Jocelyn
    Schiappa, Renaud
    Pujol, Nina
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2022, 37 : 64 - 70
  • [2] QoL and toxicity of HDR prostate brachytherapy as monotherapy 19Gy single fraction: phase II trial
    Gomez-Iturriaga, A.
    Casquer, F.
    Minguez, P.
    Espinosa, J.
    Bueso, A.
    Cacicedo, J.
    Fernandez, L.
    Pedraza, S.
    Garcia Escovedo, J.
    Bilbao, P.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S139 - S140
  • [3] MR-Guided HDR Brachytherapy Boost in Localized Prostate Cancer Results of a Phase II Trial
    Johnny, C.
    Berlin, A.
    Weersink, R. A.
    Raman, S.
    Glicksman, R.
    Catton, C.
    Rink, A.
    Warde, P. R.
    Lao, B.
    Menard, C.
    Chung, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E397 - E397
  • [4] Clinical outcomes of HDR-prostate brachytherapy 19Gy single fraction: prospective phase II trial
    Gomez-Iturriaga, A.
    Casquero, F.
    Buchser, D.
    Minguez, P.
    Espinosa, J.
    Perez, F.
    Cacicedo, J.
    San Miguel, I.
    Suarez, F.
    Pijoan, J.
    Bilbao, P.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S147 - S147
  • [5] HDR Brachytherapy as Monotherapy for Prostate Cancer: Early Toxicity of a Randomized Phase II Trial
    Jolicoeur, M.
    Derashodian, T.
    Nguyen-Huynh, T.
    Hillmann, E. de Castro
    Berbiche, D.
    Truchon, D.
    Heliou, R.
    Mondat, M.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S90 - S91
  • [6] SINGLE FRACTION HDR BRACHYTHERAPY AS ANTICIPATED BOOST IN LOCALIZED PROSTATE CANCER
    Cerrotta, A.
    Fallai, C.
    Carrara, M.
    Borroni, M.
    Villa, S.
    Bedini, N.
    Garcia, M.
    Maucione, A.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S288 - S289
  • [7] Hypofractionated EBRT and single fraction HDR brachytherapy for patients with prostate cancer
    Kazberuk, D. E.
    Filipowski, T. M.
    Szmigiel-Trzcinska, A.
    Niksa, M.
    Hempel, D.
    Topczewska-Bruns, J.
    Nowik, W.
    Pancewicz-Janczuk, B.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S973 - S973
  • [8] 5-year results of HDR brachytherapy, plus radiotherapy and ADT for intermediate prostate cancer: a phase II trial
    Jolicoeur, M.
    Tetreault-Laflamme, A.
    Nguyen-Huynh, T. V.
    Benoit, N.
    Guay, J. P.
    Fortin, B.
    Vincent, F.
    Lambert, C.
    Saad, F.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S562 - S563
  • [9] Feasibility of single fraction HDR brachytherapy in patients with prostate cancer: a planning study
    Roos, M.
    De Pan, C.
    Kolkman-Deurloo, I. K. K.
    Aluwini, S.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S267 - S268
  • [10] Clinical outcomes in localized prostate cancer treated with HDR Brachytherapy as single fraction
    Larrea, L.
    Lopez-Munoz, E.
    Antonini, P.
    Gonazlez, V.
    Banos, M. C.
    Bea, J.
    Garcia, M. A.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S975 - S975
12345